Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
And…there is a complete lack of volume…
Wrong. Only reason it’s at 7.50 is a 200 share ask slap…lol…street doesn’t lie.
LOL,
Every biotech on the planet is regulatory required to do expensive science experiments to gain approvals to then be able to produce revenues.
A revelation I'm sure.
Interesting results if you google these terms together ....... ionophore coccidiosis poultry........
First item from NIH .... second an Elanco article explaining someof the process. And several others that are interesting.
$7.50 is too cheap for where this is.
Amigo Mike
Okay Tony we know who your favorite Winnie The Pooh character is ..... Mr Eeyore :) :)
This is positive stuff coming out of ZIVO we just need to believe they are working behind the scenes and trying to get a deal done
All of this is pointless without revenue. Just another expensive science experiment like the dozens of prior studies.
Well Amigo ZIVO must be listening to you!
You got your follow through PR!
Letsssss Goooooooo!
ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study
DOWNLOAD AS PDF FEB 07, 2024
Reduction in intestinal damage enables poultry farms to optimize feed utilization
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)-- Zivo Bioscience, Inc. (OTCQB: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces additional findings from its 42-day coccidiosis challenge study that demonstrate the product’s positive impact on the cost of broiler production as an alternative to commonly-used antibiotics.
ZIVO’s product candidate for use in poultry feed is designed to boost immune response, allowing birds to effectively combat coccidiosis and reduce the negative effects of the disease without the use of antibiotics. These new results, along with earlier findings, further demonstrate the benefits of ZIVO’s product across the broiler production value chain.
ZIVO previously reported the effects of its product on the health of broiler chickens exposed to coccidiosis during the course of a 42-day grow out period, which is typical for the poultry industry. These health benefits included a statistically significant reduction in intestinal damage caused by the Eimeria parasite compared with untreated control birds. This improvement in intestinal health following parasite exposure was on par with the market-leading commercial ionophore.
ZIVO now reports that this reduction in intestinal damage enables poultry farms to optimize feed utilization as measured by the Feed Conversion Ratio (FCR), which is the primary driver of profitability. Similar to the outcomes related to intestinal damage, ZIVO’s product resulted in a statistically significant improvement in FCR compared with untreated controls. Further, these results were not statistically different from the market-leading commercial ionophore.
“We are confident that ZIVO’s product will offer poultry producers a novel tool to accelerate the development of the immune system in young birds, thereby mitigating the impact of coccidial infection, reducing intestinal tissue damage and fostering overall animal health and well-being to maximize profitability. As we further analyze the results of our most recent 42-day challenge study, we are finding that our coccidiosis treatment candidate exhibits the potential to revolutionize the industry by achieving significantly improved poultry outcomes at cost parity or better. We believe these findings will facilitate and expand dialogues with potential partners in the agriculture and animal health industries,” said John Payne, Chairman and Chief Executive Officer of ZIVO Bioscience.
About Coccidiosis
Coccidiosis is a protozoal disease that causes diarrhea, weight loss, decreased performance and increased mortality in poultry. This disease represents a significant economic challenge for the global poultry industry, as indicated by a 2020 study that estimated annual costs ranging from $10 billion to $17 billioni. Products for treating coccidiosis are mostly antibiotic- or ionophore-based, and no significant new commercial technology has been introduced in the past 60 years. The global poultry industry spends more than $1.5 billion annually on coccidiosis control, primarily using decades-old compounds that industry and consumers alike wish to replace due to the risks of developing drug resistance. Coccidiosis is a common disease for chickens, especially among young chicks, and can be fatal or result in compromised digestion.
Size bidder for 5K shares just under the market this morning at $6.80.
Personally don't think this stock should be any less than $10 and should be at least $20 after the coccidiosis test. But goes to show if you don't get the word out ... you get what you get.
5K bidder must be nutz given no one talking about ZIVO and CEO doesn't know what he's doing .... LOL.
Been looking at coccidiosis treatments and animal pharmas ....... were I Payne I'd be looking to target Zoetis, Merck Animal Health and Elanco for this.
Pretty sure Payne is on a first name basis with the C Suite at Zoetis. Payne is former CEO of Bayer Animal Health .... whose parent company happens to be Elanco. I mean far be it from me to assume Payne don't know people at Elanco eh ? Payne is also former CEO of an animal hospital chain and current ZIVO BoD member is CFO of animal hospital chain. I'm sure access to the big boyz isn't a problem.
Now getting big boyz on board for a license or co development agreement is a different story that some people seem to think is a signature ready type thing. I guarantee you is isn't that way. Been there and lived that with numerous small biotechs over the last couple decades.
I still think ZIVO needs to issue more information on the coccidiosis test. Details of the test. compares, value. All that ..... there's also question of what exactly the feed ingredient is ..... whether it is the base dried algae ... and modified version, a synthetic version. Production of it in quantity necessary to support broad distribution .... etc etc etc.
Amigo Mike
Agreed.👌 they're seriously going to be scrambling for cash soon to pay the high salaries for their eight employees who have absolutely nothing new to increase revenue for ZIVO. I've been checking trade Publications and I don't see any good news for investors
Seems this test no different than the dozen nutriquest tests with positive results. This was supposed to be different since a partner was identified initially. Then after the first test failed apparently the partner bailed. Another “show me the money” moment or stock continues to tank and we have more dilution.
My guess we will continue to drift lower (My price prediction is low 5's) but I'm assuming in ZIVO fashion we will get a random update and then we pop again.
100 share lots seem to really push things one way or the other now that we have broken past 5
Based on past practices , insiders will let this go below $5 and buy shares through private placement at these levels since the company will need cash soon. I wouldn’t buy more until then.
I am not new to zivo. I was around long before there was a hype train. I got overly excited once the 42-day test was initiated. I assumed incorrectly that management would be shaking hands and creating the buzz. Anyway, moving on, over 2,000 shares sold today. I'm still holding. Hard to get over $10 when people are selling out
Good for insiders who want to lower their cost basis. Seems like they are the only investors who get the privilege of buying outside the public market.
Anyway .....
.... It is looking like ZIVO is purposely being held under $10 with lack of action. That is a psychological number that we need to maintain above for next move.
Not helped by ZIVO silence on the tests here is not good for us ... or the company.
Amigo Mike
I agree,
But feels far too "immediate" to me. We all have same concerns about this company. But I'm not sure anyone here expected to see immediately anything besides of course reaction of the stock.
Amigo Mike
Ohio, I think your current reasoning is valid, though I am curious what justifications you operated on while on the hype train.
Attack ?
That is hilarious. I didn't say anything other than selling out and deciding to bash the company. 1 day you are bullish, the next you are saying the company is worthless. And ya did say the "company is worthless".
It actually wasn't a response by Amigo, it was more of an attack. And an unwarranted one. I provided a valid justification on why I no longer have faith in zivo ownership/management
I said the stock was worthless. Not the product. There's a difference. I have zero faith in a company that doesn't communicate or know how to properly Market a product. So y'all go ahead and pile on the hate. Yeah I made my money back. But I also didn't sell most of my Zivo stock. But I have lost interest in what the stock is going to do. I've got a few other that I'm far more interested in. But you all take care and I hope it works out for you..... salty asf, huh? That's okay I can be your whipping post😂 don't know any of you. You can hate on me all you want. All I did was Express I changed my opinion. I follow the science. And right now that science isn't leading to any published articles. Or any licensing agreements🫡
Ah,
So put another way .... ya got your money back and now you don't believe in anything and bash the stock. Company is "worthless". Got it.
Yes mgmt of this company leaves so so much to be desired. No question about that. And the level of communication is atrocious.
The test result news was a week ago. Dunno why anyone would expect news on partner or license immediately. But to each his own.
Amigo Mike
I'm even. No loss on my end. At this point I'm just sticking around to see what happens out of curiosity. Lack of imperative industry articles/ publishing / zero communication is why I have lost faith.
100% believe the product works. My "apprehension" is regarding infrastructure and implementation. Same apprehension I've always had. But I took the Gamble and bought the stock. ZIVO doesn't have the ability to scale it for mass production. Never has, they're an R&D company. Doesnt look like they have anybody on the hook who wants to be involved in licensing & production- the golden rolodex isn't helping. There must be something making it unattractive even with positive results.
Questions regarding production/cost/logistics on a wide scale for agricultural implementation is my guess. It doesn't matter if it can save the industry over 9 billion dollars a year in losses. If it can't be mass produced & distributed at a reasonable cost, then it's not a solution for our poultry losses. We'll still be burning barns and killing birds.
I made an incorrect assumption that the stock should be well over $20 by now.... it can't even hold $10 for 10 days in a row. It's disappointing.
WOW,
That is a complete 180 from prior ........ so ....... what's changed ?
In my neophyte opinion, whomever is scooping up warrants at $33 is a fool - the company is worthless. Bet it's less than a dollar a share in our very near future. I have zero faith the product is going to be sold or marketed by ZIVO. What a waste.
I thought Payne had a “golden Rolodex”? Seems like by now he would have spoken to industry leaders and publications if this was the case. All I see is more busy work by the CFO with this pointless uplisting to justify his salary.
Amigo, sorry for the confusion. Doing too many things LOL
Yesterday CNBC had an article about big pharma products patents expiring and needing the "next big thing"
https://www.cnbc.com/2024/01/28/big-pharma-merck-bristol-myers-jj-prepare-to-lose-revenue.html
Gwinner,
CNBC doesn't cover pink/otc companies.
I am looking for INDUSTRY PUBLICATIONS ... interviews .... BUZZ .... OUTRAGE FROM PEOPLE THE INDUSTRY NEEDS THIS.
This need to be widely distributed and understood and people need to understand the implications and what it means for HUMAN FOOD SUPPLY.
Amigo Mike
Algaeboy,
The ingredient is mixed with the chicken feed. What it actually is .... the raw algal biomass dried and powdered .... or a modified version .... I can't say that I know that specifically. My understanding is this is covered by worldwide patents .... but you can't patent naturally occurring substances. So there is certainly process.
Either way, I agree with you 100%. ZIVO NEEDS TO PUT OUT MORE INFORMATION ON THE DETAILS OF THIS TEST. PAINT THE PICTURE FOR THE MARKETS. PAINT THE PICTURE OF THE INDUSTRY AND MARKET DEMANDS FOR NON ANTIBIOTIC TREATMENTS.
It always seems to me that ZIVO mgmt and BoD is totally clueless that they are a public company and have no money. YOU DON"T WANT TO RAISE MONEY AT THE LOWEST PRICES which ZIVO has been forced to do multiple times. THEY CONTROL THE SILENCE AND THE MESSAGE. If they haven't learned in 10+ years ... SILENCE DOESN"T WORK. And who knows, maybe there are OTHER COMPANIES THAT MIGHT BE INTERESTED IN GETTING INVOLVED. If you don't speak up and represent yourself, IS SOMEONE ELSE GOING TO DO IT ? Not likely.
This is a bit why I am leaning toward ZIVO company sale as a whole at this point. They've proven the chicken candidate in real world growing conditions. By now they should have proven others .... but it is what it is .... I can see these guys getting a license or whatever .... but then going through this process again for another candidate ..... MULTIPLE MORE YEARS FOR NEXT CANDIDATE ISN"T GOING TO CUT IT. They rely on everyone else to do this stuff. It takes at least multiple times longer than a company with inhouse staff. Dunno what the PHDs in Fort Myers do but if they aren't working other candidates and options .... then they are worthless. It is designed to be sold ..... SELL IT.
Be interesting to see what happens with $10 this week. IMO, it should be vigorously defended by investors as double digits is a big deal for a stock that is risin out of the abyss. Maintaining $10 not only sets stage for next move .... but if by chance ZIVO tries raising more money .... THE DILUTIVE EFFECT IS VASTLY DIFFERENT.
So ..... let's see what happens here. Someone is taking in a ton of warrants that have a $33 strike creating alot of leverage but the stock has got to move up for that to pay off.
ZIVO going silent IS NOT THE ANSWER.
Amigo Mike
Thats a nice find Amigo
There was a similar article on CNBC yesterday
Mike,
Last project update from Z 9/23/22… now would be the perfect time for the company to give some details about what occurred during the most recent 42 day testing with the chickens… One of the many questions I have, is, how was the algae administered to the chickens?… Was it a 100% natural application using nothing but the dried algae added to the chicken’s food, and if so, how much was needed to achieve the desired results, and how will the supply demands be handled moving forward?… And if the algae was not administered, naturally, is their some type of pharmaceutical application being developed with the rarely-never mentioned anymore molecule the world needs to know about?… So many more questions, but that’s it for now…
First industry article that I've seen.
https://www.myvetcandy.com/blog/2024/1/27/biotech-breakthrough-zivo-bioscience-unveils-revolutionary-non-antibiotic-treatment-for-poultry-disease
Payne needs to release more trial result info.
And there needs to be a dozen of these articles in industry publications.
Amigo Mike
Yeah,
I'm pretty sure they didn't do the split proper on the public warrants ..... cause the SEC filings make it look like they did.
And there are those pesky details around registered shares .... which the offering and warrants were originally covered by a specific number of registered shares. ZIVO would have a problem were those warrants to become exercisable as they can't issue 3 million shares on them under the registration statement at least IMO. As noted prior to RS ZIVO reported nearly 3 million of these ... after ... they are reporting 495k. So they need to correct / clarify these. Marchiando still silent. And strangely no response from ZIVO legal who usually at least responds with at least acknowledgement of receipt.
Hell I don't care if they screwed it up and maybe now you get 1/6th of a share on warrant exercise ..... whatever the current terms are, just need to know because if this thing GOES TO THE MOON .... it is serious monetary difference.
Case in point ... if you owned 10,000 warrants pre split of course the strike was $5.50. Now saying the strike is $33 but no RS of the warrants happened.
IMO, it should be 1,667 warrants at $33.
But if ZIVO for some reason rockets to say $50 like we would all like .... the warrant should certainly bridge the gap between strike and price meaning it should be worth $17 / warrant. Well ..... owning 10,000 of these is big money ... $170K ..... owning 1,667 of those is still big money at $28.3K ..... but a MASSIVE difference.
Just need clarity on the outstanding and the terms. Maybe I'm totally off base but my understanding is these all fit under a registration statement filed with the SEC for a specific number of shares which have since gone through an RS.
Amigo Mike
So the volume should answer your earlier question of "did the reverse split the warrants..." apparently they didn't or this would have been to the moon with this type of volume.
As ZIVO keeps quiet the stock will drift lower until the next newzzy item
So we wait....
Someone is surely working on creating a highly leveraged position in those warrants. One that would take a sharp move upward in the stock to cash in on.
There is time decay on these just like options. Right now they are on fire and the demand is there.
Amigo Mike
Mr .4250 still wanting all your warrants
Mr .4250 aint budging and gobbling them all!
I love the ZIVO Warrants churning today!
313,000 shares !
So who is scooping all the warrants today ?
Over 250K traded so far with another 42k available on the ask at .45.
Amigo Mike
Welp,
Did some chart work last night .... and to me ...... we are probably in a resistance zone ..... ZIVO spent a few months in the $10-$13 range starting in July before death spiral starting in mid September to the November lows.
So not a surprise to me if there is some consolidation here for a bit between $10 and $13. That said ... anything can happen. But I think the $10 level should be vigorously defended by ZIVO investors if need be. And still think minimum target is $20 prior to hearing a license type PR as that is where the stock was at the time of the first test failure before dropping to the aforementioned area in July.
I would really like to see a more PR from ZIVO on the chicken test highlighting its details and results relative to the standards of today. Can't go silent here for months. In addition, they should be all over social media and industry publications for interviews and generating buzz. My guess is they are clueless on that aspect.
So ZIVO NEEDS TO MARKET ITSELF AND REALIZE WHAT INFORMATION DOES FOR THE COMPANY AND ITS FUTURE.
Amigo Mike
There were several applications mentioned, but lack of clarity on the status of each. This has been one giant science experiment and now hopefully there is a desire to make this a real money making business. The only people who previously made money were lazy executives and scientists.
My plan would be sell the rights to coccidiosis treatment and prevention, put money into marketing a product like AG1 (ride the green drink bandwagon) assuming growing and harvesting issues resolved (certainly plenty of money and time went into this) and then move into other animal application. Assume bovine mastitis treatment had some promise and now they should have the money and better documented science to get a partner to help fund R&D
Welp,
After the morning action ZIVO is back in positive territory and uptick ..... and honestly looking very very thin at the moment. I suppose those that wanted to do something this morning went and did their business ..... but back to super thin and I suspect a whisper moves this stock one way or another.
Need ZIVO to bring more news to the markets. No fluffy BS. Meat and potatoes.
Amigo Mike
This dump ... hell .... LOL .... I didn't expect it but now considering rolling back in with buys .....
Warrants getting more action today as well. Could be some stock selling to buy warrants but ultimately the warrants need buying the stock to continue.
Amigo Mike
Tony, correct me if I'm wrong but its more than just coccidiosis and cholesterol. I can't pull up old reports but I recall they had a list intellectual properties that they have patents on that could be part of the package. Thats why I indicated it would be nice if they tapped large pharma that handles both animal and human pharma
They have the patent for the synthetic molecule. There was some discussion on human cholesterol treatment years ago according to PRs. While I would like quick cash, seems like a waste to sell everything just for coccidiosis.
My guess some people are just selling the news. Thats okay though let it drift lower, I'll buy more. Still havent sold a share and hanging on to my warrants
Gee,
I hope my note wasn't taken as .... go to town .... selling or outright sell. Some big offers pushing down since my trim note. If you are trying to sell a little .... this is so tight .... ya need to bleed out in small chunks ... not thousands of shares at a time.
I'm still in the camp this keeps rising to at least $20 but folks certainly need to do you and do whatchya got to.
This is why the clowns need some followup PR and buzz. There is ZERO buzz on social media on ZIVO. The news should be sent out to all poultry industry publications.
Amigo Mike
Unless they plan on "running" the company for other future developments, I see no reason to uplist back to NASDAQ. It seems it would be a huge cash drain to stay compliant. IMO better to use those remaining resources to put a "book" together and go on the road show and cut a deal with big PHARMA. Particularly one that deals in BOTH animal and human pharma.
Nice bounce out of the gate again this morning ..... following recent patterns.
In the spirit of disclosure ..... and for anyone that might be tailing what I am doing ..... having bought swing position at avg 62 cents .... I bled out 10% of my swing position at $12.50. Covering full swing cost and taking some profit out. Deciding on what's next. But 20 bags is probably one of the best outcomes I think I've ever had for a swing trade. I've had 100 bag+ long term winners but for short term swings ... this one has been quite the trade.
I'm still the in camp ... this damn thing should be $20 on this positive test result by itself. Again ZIVO thin on details and timing of anything for next steps. But $20 just put the stock back where it was when the first test failed. Now with those positive results in hand .... there is plenty of reason to believe this thing should be higher.
Amigo Mike
Followers
|
65
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
9188
|
Created
|
09/14/05
|
Type
|
Free
|
Moderators Amigo Mike |
------------------------------------------------------------
http://www.zivobioscience.com
Contact Information:
Zivo Bioscience, Inc.
2804 Orchard Lake Road, Suite 202
Keego Harbor, MI 48320
Telephone : (888) 871-6903
(248) 452-9866
info@zivobioscience.com
Wellmetrix Subsidiary
http://www.wellmetrix.com
Peer Reviewed Human Clinical Trial Results published in LipidWorld: www.lipidworld.com/content/pdf/1476-511x-6-20.pdf
Scientific Panel Presentation June 8, 2010: www.visualwebcaster.com/VWP/Player/advplayer.html
Nutraceutical World Article October 2010: www.nutraceuticalsworld.com/contents/view/29644
Journal: Nutrition and Dietary Supplements (peer reviewed) www.dovepress.com/getfile.php?fileID=13045
Journal: Nutrition & Metabolism (peer reviewed) http://www.nutritionandmetabolism.com/content/10/1/55
Press releases: http://finance.yahoo.com/q?s=ZIVO
Chart:
http://schrts.co/eKWAzdTA
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |